Compounds / Tissue Repair / Matrixyl

Matrixyl

Matrixyl (Palmitoyl Pentapeptide-4, pal-KTTKS)
Tissue RepairFDA: Not FDA-regulated as drug — cosmetic...

Overview

Most studied cosmeceutical peptide. Clinical studies show 27-44% reduction in wrinkle depth after 4 months. Comparable to retinol without irritation. Developed by Sederma (Croda).

Mechanism of Action

Lipopeptide from procollagen I C-terminal propeptide. Penetrates skin via palmitoyl moiety, activates fibroblasts by mimicking matrikines. Stimulates collagen I, III, IV, fibronectin, and hyaluronic acid via TGF-beta signaling.

Molecular Profile

Molecular weight
802.1 Da
CAS number
214047-00-4

Key Research Findings

27-44% wrinkle reduction; stimulates collagen synthesis; palmitoyl increases penetration 6x; retinol-comparable efficacy.

Published Research

J Biol Chem
Pentapeptide promotes extracellular matrix production
View source
Int J Cosmet Sci
Palmitoyl pentapeptide on skin aging
View source

Related Tissue Repair Compounds

BPC-157TB-500AHK-CuKPVMGFPEG-MGF
Clinical Guidance

Research data is not a treatment plan. If you are considering Matrixyl, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running Matrixyl? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals